Difference between revisions of "Sahebjam S, et al. Br. J. Cancer (2013) cited as Ref 589 in DOI: 10.1038/s41392-020-0110-5 (Q9852)"

@@ Property / Publication Date @@
+Timestamp +2013-01-01T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 year
Before 0
After 0
-Timestamp
++2013-01-01T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+year
 Before
 After
@@ Property / Publication Date: 2013 / rank @@
+Normal rank
@@ Property / Published In Name String @@
+Br. J. Cancer
@@ Property / Published In Name String: Br. J. Cancer / rank @@
+Normal rank
@@ Property / Volume @@
@@ Property / Volume: 109 / rank @@
+Normal rank
@@ Property / title @@
+A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503) (English)
+Normal rank
@@ Property / Page(s) @@
+-949
@@ Property / Page(s): 943-949 / rank @@
+Normal rank

Latest revision as of 15:46, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

Language	Label	Description	Also known as
English	Sahebjam S, et al. Br. J. Cancer (2013) cited as Ref 589 in DOI: 10.1038/s41392-020-0110-5	Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8